The University of Liverpool is leading a £2.7 million clinical trial to investigate vagus nerve stimulation as a treatment for people with drug-resistant epilepsy.
Black recipients of liver transplants have lower post-transplant survival rates than white or Hispanic patients, according to a new study from Keck Medicine of USC.
Dr Lynn Woods, Professor in the Department of Doctoral Programs, School of Nursing, Azusa Pacific University, explores behavioural symptoms of dementia in the Latinx population.
Professor Heather Sheardown from McMaster University provides detail about treating vision-related conditions, including injectable, in situ gelling systems.
Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.
Dr Faz Chowdhury, CEO at Nemaura Medical (Nasdaq: NMRD), aims to stem the tide of the onset of diabetes and help to manage and reverse Type 2 diabetes using the world’s first daily-wear non-invasive CGM technology.
Michelle Davis, Head of External Relations at Malaria Consortium, shares with us what we need to know about learning from COVID-19 and the continuing fight against malaria.
African swine fever is placed under the spotlight here by Prof. Dr. José Manuel Sánchez-Vizcaíno, Full Professor of Animal Health at Universidad Complutense de Madrid.
Over half of global cardiovascular disease (CVD) deaths in 2019 happened in Asia - now, scientists are drawing attention to rapidly climbing figures, as heart issues continue to be a risk factor for severe COVID.
Earlier this year, Yourgene Health entered into a collaboration with Cytox to run their genoSCORE-LAB assay in our laboratory. genoSCORE-LAB™ is a new non-invasive test that can predict the risk of an individual developing Alzheimer’s disease from a simple saliva sample.
